February 25, 2017 6:16 PM ET

Pharmaceuticals

Company Overview of Merck Serono S.A.

Key Executives for Merck Serono S.A.

NameBoard RelationshipsTitleAge
Belén Garijo López M.D.29 RelationshipsChief Executive Officer, President and Member of the Executive Board56
Simon J. Sturge 5 RelationshipsChief Operating Officer57
Randall James Bradford No RelationshipsGlobal Head of Human Resources and Senior Vice-President--
Monika Dorda No RelationshipsGlobal Head of Legal, Senior Vice President of Merck Healthcare and General Counsel of Merck Healthcare--
Alise Reicin M.D.No RelationshipsHead of Global Clinical Development and Senior Vice President--
View More Key Executives

Merck Serono S.A. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Francois Naef 8 RelationshipsMerck Serono S.A.53
Ronald M. Lindsay Ph.D. 28 RelationshipsZebra Biologics, Inc.68
Elmar J. Schnee B.Com., M. Mktg. 52 RelationshipsMindMaze SA57
Axel Von Wietersheim 10 RelationshipsBiomet Europe BV--
Josef Dubacher 8 RelationshipsMerck Serono S.A.--
View All Board Members

Merck Serono S.A. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
343.5K
Bonus
400.9K
Total Short Term Compensation
485.2K
Total Value of Options
15.0M
Compensation as of Fiscal Year
Merck Serono S.A. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sumitomo Dainippon Pharma Co., Ltd. Announces Executive Changes
February 24, 2017 3:00 PM ET
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers
February 24, 2017 7:02 AM ET
Jun Hishida to Retire as Executive Vice President of Kitasato Daiichi Sankyo Vaccine Co., Ltd, Effective March 31, 2017
February 24, 2017 7:02 AM ET
CCM Duopharma Biotech Berhad Announces the Resignation of Byung-Geon Rhee as Independent and Non Executive Director, Effective February 25, 2017
February 24, 2017 4:35 AM ET
RespireRx Pharmaceuticals Inc. Announces Management Changes
February 23, 2017 10:28 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Merck Serono S.A., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.